Filter
1385
Text search:
pharmaceutical
products
Featured
128
384
Language
Document type
679
271
222
78
64
29
23
10
6
1
1
1
Countries / Regions
65
49
48
46
31
30
29
26
24
24
24
23
21
19
18
18
17
15
15
14
14
13
13
13
12
11
9
9
8
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
569
103
67
44
38
37
10
1
Toolboxes
178
161
90
65
61
57
41
40
26
25
25
24
20
19
15
9
7
7
6
6
3
1
1
Soumis à l’Agence des États-Unis pour le développement international par le programme SIAPS (Systems for Improved Access to Pharmaceuticals and Services ou Programme des systèmes pour l’amélioration de l’accès aux produits et services pharmaceutiques). Arlington, VA : Management Sciences
...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its objectives are to minimize
...
Health Evidence Network synthesis report 72
Lancet Glob Health 2021 Published Online December 13, 2021 https://doi.org/10.1016/S2214-109X(21)00463-
Med J DY Patil Univ 2017;10:229-33
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report.
The document contains 2 decision trees, the first short one is to act fast and the second is to design better interventions
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Economic Issues, Policies and Option for Action
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
